Replies to post #47043 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

iBliss at its peak two years ago maintained healthy sales of $15,000,000 with 40% profit margins, but are once again on the rise and projected to again reach $15,000,000 due to recently executed new international distribution agreements.